BAJAJ BROKING

Notification
No new Notification messages
Nisus Finance Services IPO is Open!
Apply for the Nisus Finance Services IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
zim laboratories limited stock

ZIM LABORATORIES LIMITED Share Price

124.09 9.00 (7.81%)
Dec 04 2024 03:30 PM Pharmaceuticals NSE: ZIMLAB

ZIM LABORATORIES LIMITED Share Price Update

As of the latest trading session, ZIM LABORATORIES LIMITED share price is currently at 124.09, which is up by 9.00 from its previous closing. Today, the stock has fluctuated between 117.51 and 128.00. Over the past year, ZIM LABORATORIES LIMITED has achieved a return of 1.44 %. In the last month alone, the return has been 9.45 %. Read More...

ZIM LABORATORIES LIMITED Performance

Day Range

Low117.51 High128.00
124.09

52 Week Range

Low 89.50 High 131.40
124.09

ZIM LABORATORIES LIMITED Share Price

12384

541400

ZIMLAB

img img img img
No Data Available

Open Price

119.40

Prev. Close

115.09

Volume (Shares)

2533199.00

Total traded value

3143.44

Upper Circuit

138.10

Lower Circuit

92.07

Note: The current prices & values are delayed, Login to your account for live updates.

ZIM LABORATORIES LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 604.63
PE Ratio (TTM) 41.18
Book Value / Share 48.10
Beta 1.10
ROE 7.87%
EPS (TTM) 3.02
Dividend Yield 0.00%
Net Profit Qtr (Cr) 1.22

ZIM LABORATORIES LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 89.72
Operating Expense 89.20
Net Profit 1.22
Net Profit Margin (%) 1.35
Earnings Per Share (EPS) 0.25
EBITDA 9.71
Effective Tax Rate (%) 34.59
Particulars JUN 2024 (Values in Cr)
Revenue 82.00
Operating Expense 81.90
Net Profit 0.76
Net Profit Margin (%) 0.92
Earnings Per Share (EPS) 0.16
EBITDA 8.86
Effective Tax Rate (%) 30.55
Particulars MAR 2024 (Values in Cr)
Revenue 117.39
Operating Expense 108.12
Net Profit 7.89
Net Profit Margin (%) 6.72
Earnings Per Share (EPS) 1.62
EBITDA 16.95
Effective Tax Rate (%) 26.94
Particulars DEC 2023 (Values in Cr)
Revenue 95.82
Operating Expense 89.92
Net Profit 4.83
Net Profit Margin (%) 5.04
Earnings Per Share (EPS) 0.99
EBITDA 12.29
Effective Tax Rate (%) 31.09
Particulars SEP 2023 (Values in Cr)
Revenue 85.26
Operating Expense 81.23
Net Profit 4.18
Net Profit Margin (%) 4.90
Earnings Per Share (EPS) 0.86
EBITDA 10.39
Effective Tax Rate (%) 23.30
Particulars MAR 2024 (Values in Cr)
Revenue 365.47
Operating Expense 347.12
Net Profit 16.76
Net Profit Margin (%) 4.58
Earnings Per Share (EPS) 3.44
EBITDA 44.79
Effective Tax Rate (%) 27.25
Particulars MAR 2023 (Values in Cr)
Revenue 396.53
Operating Expense 367.05
Net Profit 25.01
Net Profit Margin (%) 6.30
Earnings Per Share (EPS) 5.13
EBITDA 57.62
Effective Tax Rate (%) 30.37
Particulars MAR 2022 (Values in Cr)
Revenue 329.49
Operating Expense 314.71
Net Profit 13.01
Net Profit Margin (%) 3.94
Earnings Per Share (EPS) 8.01
EBITDA 42.45
Effective Tax Rate (%) 32.53
Particulars MAR 2021 (Values in Cr)
Revenue 303.63
Operating Expense 292.32
Net Profit 5.62
Net Profit Margin (%) 1.85
Earnings Per Share (EPS) 3.46
EBITDA 34.08
Effective Tax Rate (%) 34.49
Particulars MAR 2020 (Values in Cr)
Revenue 274.32
Operating Expense 280.46
Net Profit 1.74
Net Profit Margin (%) 0.63
Earnings Per Share (EPS) 1.07
EBITDA 24.43
Effective Tax Rate (%) 216.77
Particulars MAR 2024 (Values in Cr)
Book Value / Share 49.00
ROE % 7.86
ROCE % 9.97
Total Debt to Total Equity 0.40
EBITDA Margin 12.66
Particulars MAR 2023 (Values in Cr)
Book Value / Share 41.12
ROE % 12.99
ROCE % 16.65
Total Debt to Total Equity 0.31
EBITDA Margin 14.65
Particulars MAR 2022 (Values in Cr)
Book Value / Share 108.18
ROE % 8.65
ROCE % 12.43
Total Debt to Total Equity 0.40
EBITDA Margin 13.61
Particulars MAR 2021 (Values in Cr)
Book Value / Share 98.97
ROE % 7.01
ROCE % 10.80
Total Debt to Total Equity 0.55
EBITDA Margin 13.70
Particulars MAR 2020 (Values in Cr)
Book Value / Share 95.06
ROE % 2.16
ROCE % 5.38
Total Debt to Total Equity 0.55
EBITDA Margin 9.77
Particulars MAR 2024 (Values in Cr)
Book Value / Share 47.60
ROE % 7.87
ROCE % 9.99
Total Debt to Total Equity 0.41
EBITDA Margin 12.26
Particulars MAR 2023 (Values in Cr)
Book Value / Share 39.85
ROE % 13.73
ROCE % 17.30
Total Debt to Total Equity 0.32
EBITDA Margin 14.53
Particulars MAR 2022 (Values in Cr)
Book Value / Share 104.73
ROE % 7.95
ROCE % 11.92
Total Debt to Total Equity 0.41
EBITDA Margin 12.88
Particulars MAR 2021 (Values in Cr)
Book Value / Share 96.69
ROE % 5.84
ROCE % 10.24
Total Debt to Total Equity 0.56
EBITDA Margin 12.93
Particulars MAR 2020 (Values in Cr)
Book Value / Share 93.79
ROE % 1.15
ROCE % 4.74
Total Debt to Total Equity 0.55
EBITDA Margin 8.91
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 10.46
Total Assets 446.82
Total Liabilities 446.82
Total Equity 238.74
Share Outstanding 48725814
Price to Book Ratio 2.01
Return on Assets (%) 3.85
Return on Capital (%) 5
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 7.51
Total Assets 341.57
Total Liabilities 341.57
Total Equity 200.34
Share Outstanding 48725814
Price to Book Ratio 1.82
Return on Assets (%) 7.15
Return on Capital (%) 9.4
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.97
Total Assets 341.62
Total Liabilities 341.62
Total Equity 175.70
Share Outstanding 16241938
Price to Book Ratio 1.53
Return on Assets (%) 4.25
Return on Capital (%) 6.41
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 8.35
Total Assets 324.78
Total Liabilities 324.78
Total Equity 160.75
Share Outstanding 16241938
Price to Book Ratio 0.75
Return on Assets (%) 2.25
Return on Capital (%) 3.03
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 3.95
Total Assets 325.30
Total Liabilities 325.30
Total Equity 153.82
Share Outstanding 16180722
Price to Book Ratio 0.60
Return on Assets (%) 1.01
Return on Capital (%) 1.43
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.75
Total Assets 442.50
Total Liabilities 442.50
Total Equity 231.95
Share Outstanding 48725814
Price to Book Ratio 2.01
Return on Assets (%) 3.78
Return on Capital (%) 4.95
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2.20
Total Assets 334.86
Total Liabilities 334.86
Total Equity 194.17
Share Outstanding 48725814
Price to Book Ratio 1.82
Return on Assets (%) 7.46
Return on Capital (%) 9.86
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.09
Total Assets 335.42
Total Liabilities 335.42
Total Equity 170.10
Share Outstanding 16241938
Price to Book Ratio 1.53
Return on Assets (%) 3.87
Return on Capital (%) 5.88
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 7.86
Total Assets 320.27
Total Liabilities 320.27
Total Equity 157.04
Share Outstanding 16241938
Price to Book Ratio 0.75
Return on Assets (%) 1.75
Return on Capital (%) 2.36
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 2.82
Total Assets 322.86
Total Liabilities 322.86
Total Equity 151.75
Share Outstanding 16180722
Price to Book Ratio 0.60
Return on Assets (%) 0.53
Return on Capital (%) 0.76
Particulars MAR 2024 (Values in Cr)
Net Income 23.64
Cash from Operations 18.86
Cash from Investing -73.01
Cash from Financing 59.53
Net change in Cash 3.17
Free Cash Flow 92.78
Particulars MAR 2023 (Values in Cr)
Net Income 35.35
Cash from Operations 45.31
Cash from Investing -36.20
Cash from Financing 0.54
Net change in Cash 3.00
Free Cash Flow 81.98
Particulars MAR 2022 (Values in Cr)
Net Income 21.04
Cash from Operations 49.63
Cash from Investing -14.57
Cash from Financing -32.97
Net change in Cash 2.02
Free Cash Flow 64.86
Particulars MAR 2021 (Values in Cr)
Net Income 15.41
Cash from Operations 32.96
Cash from Investing -5.88
Cash from Financing -25.97
Net change in Cash -0.06
Free Cash Flow 39.44
Particulars MAR 2020 (Values in Cr)
Net Income 0.06
Cash from Operations 26.87
Cash from Investing -19.40
Cash from Financing -2.16
Net change in Cash 0.95
Free Cash Flow 45.40
Particulars MAR 2024 (Values in Cr)
Net Income 23.03
Cash from Operations 14.04
Cash from Investing -71.94
Cash from Financing 59.53
Net change in Cash -0.93
Free Cash Flow 86.63
Particulars MAR 2023 (Values in Cr)
Net Income 35.91
Cash from Operations 42.21
Cash from Investing -35.20
Cash from Financing 0.54
Net change in Cash 0.56
Free Cash Flow 77.88
Particulars MAR 2022 (Values in Cr)
Net Income 19.29
Cash from Operations 47.25
Cash from Investing -14.41
Cash from Financing -32.97
Net change in Cash -0.36
Free Cash Flow 62.22
Particulars MAR 2021 (Values in Cr)
Net Income 13.76
Cash from Operations 32.95
Cash from Investing -5.70
Cash from Financing -25.96
Net change in Cash 0.23
Free Cash Flow 39.25
Particulars MAR 2020 (Values in Cr)
Net Income -1.48
Cash from Operations 26.20
Cash from Investing -18.81
Cash from Financing -2.16
Net change in Cash 0.31
Free Cash Flow 40.98
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 58.42 33.57 3.18 447.69 37.54 / 77.70
BLISS GVS PHARMA LTD 163.60 20.48 1.70 1722.74 92.25 / 172.40
CIPLA LTD 1534.40 26.84 4.36 123920.06 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 406.85 141.27 4.12 1197.40 145.00 / 413.80
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 58.42 50.80 9.93 447.69 37.54 / 77.70
AMRUTAJAN HEALTH LTD 749.60 45.60 7.27 2167.14 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6597.95 128.14 24.28 16494.88 4050.15 / 8139.85
BLISS GVS PHARMA LTD 163.60 21.30 1.68 1722.74 92.25 / 172.40

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 113.00
  • 26 Days 108.50
  • 10 Days 110.30
  • 50 Days 108.50
  • 12 Days 109.50
  • 100 Days 109.60
  • 20 Days 109.20
  • 200 Days 105.80
114.22
PIVOT
First Resistance 116.70
Second Resistance 118.30
Third Resistance 120.78
First Support 112.62
Second Support 110.14
Third Support 108.54
RSI 60.67
MACD 0.98
Commodity Channel Index (CCI) 107.11
ADX 13.67
Williams % R -11.18

Over 1 Month

down

9.45

Over 3 Months

down

-3.60

Over 6 Months

down

11.03

Over 1 Year

down

1.44

Over 3 Years

down

0.87

Over 5 Years

down

0.00

ZIM LABORATORIES LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

ZIM LABORATORIES LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
66.62
Promoter Holdings
33.26
FII
0.0
DII
0.1
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Anwar Daud Shareholding of Promoter and Promoter Group 1.333632E7 27.37
Zakir S Vali Public Shareholding 5047420.0 10.36
Mathew Cyriac Public Shareholding 4791824.0 9.83
Elimath Advisors Private Limited Public Shareholding 1642336.0 3.37
Sabbah Zulfiquar Kamal Shareholding of Promoter and Promoter Group 1500000.0 3.08
Bonanza Business Services Pvt Ltd Public Shareholding 1240000.0 2.54
Zulfiquar Murtuza Kamal Shareholding of Promoter and Promoter Group 1195260.0 2.45
Dr Iguer Abdelmounaim Public Shareholding 1165680.0 2.39
Jyoti Bharat Sheth Public Shareholding 670943.0 1.38
Laadki Trading And Investments Limited Public Shareholding 669120.0 1.37
Hasan Kamal Shareholding of Promoter and Promoter Group 104400.0 0.21
Shabbar Daud Shareholding of Promoter and Promoter Group 42000.0 0.09
Tasneem Anwar Daud Shareholding of Promoter and Promoter Group 30000.0 0.06

ZIM LABORATORIES LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2019-09-19 0.5 Final 2019-09-23 Equity shares 2018-09-03 1.0 Final 2018-09-04 Equity shares
Ex-Date Ex-Bonus Ratio
2022-12-22 2022-12-22 2:1 2018-10-06 2018-10-04 1:1
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About ZIM LABORATORIES LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by ZIM LABORATORIES LIMITED

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Zim Laboratories Ltd?

Answer Field

The share price of Zim Laboratories Ltd for NSE is ₹ 124.09 and for BSE is ₹ 124.35.

What is the Market Cap of Zim Laboratories Ltd?

Answer Field

The market cap of Zim Laboratories Ltd for NSE is ₹ 6,04.63 Cr. and for BSE is ₹ 6,05.90 Cr. as of now.

What is the 52 Week High and Low of Zim Laboratories Ltd?

Answer Field

The 52 Week High and Low of Zim Laboratories Ltd for NSE is ₹ 131.40 and ₹ 89.50 and for BSE is ₹ 131.30 and ₹ 89.90.

How to Buy Zim Laboratories Ltd share?

Answer Field

You can trade in Zim Laboratories Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Zim Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been 1.44%.

What is the Current Share Price of Zim Laboratories Ltd?

Answer Field

Zim Laboratories Ltd share price is for NSE ₹ 124.09 & for BSE ₹ 124.35 as on Dec 04 2024 03:30 PM.

What is the Market Cap of Zim Laboratories Ltd Share?

Answer Field

The market cap of Zim Laboratories Ltd for NSE ₹ 6,04.63 & for BSE ₹ 6,05.90 as on Dec 04 2024 03:30 PM.

What is the P/E Ratio of Zim Laboratories Ltd Share?

Answer Field

As on Dec 04 2024 03:30 PM the price-to-earnings (PE) ratio for Zim Laboratories Ltd share is 41.18.

What is the PB ratio of Zim Laboratories Ltd Share?

Answer Field

As on Dec 04 2024 03:30 PM, the price-to-book (PB) ratio for Zim Laboratories Ltd share is 48.10.

How to Buy Zim Laboratories Ltd Share?

Answer Field

You can trade in Zim Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Zim Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Zim Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Zim Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader